More on ARMP

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+2.2% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Armata Pharma (NY:ARMP)
Delayed: 4.51 +0.75 (19.95%)
Prev. Close $3.76  
Open$3.81 
52 Wk High$2.00 
52 Wk Low$1.50 
Day High$4.55 
Day Low$3.80 
P/E N/A  
EPS$0.00 
Volume271,344 


Jul 14, 2026 04:19 PM Form 4 Armata Pharmaceuticals, For: Jul 10 Filed by: Birx Deborah
Jul 13, 2026 07:12 AM Form 8-K Armata Pharmaceuticals, For: Jul 13
Jul 13, 2026 07:00 AM FDA agrees to Armata's pediatric study plan for AP-SA02 bacteremia drug
Jul 13, 2026 07:00 AM Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia
Jul 13, 2026 06:02 AM Form S-8 Armata Pharmaceuticals,
Jun 24, 2026 04:19 PM Form 8-K/A Armata Pharmaceuticals, For: Apr 24
Jun 23, 2026 07:11 AM Form 8-K Armata Pharmaceuticals, For: Jun 23
Jun 23, 2026 07:01 AM Armata gets $2.5M more in DoD funding for bacteriophage drug
Jun 23, 2026 07:00 AM Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02
Jun 16, 2026 04:44 PM Form 8-K Armata Pharmaceuticals, For: Jun 11
View All Articles

Entities mentioned with ARMP

View All Entities